After appropriate washout from angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), all patients included were started on sacubitril/valsartan on top of their previous HF medical therapy, including beta-blockers, mineralocorticoid receptor antagonists (MRAs), and diuretics. Here, NR3C2 is linked to hydrops fetalis.